Literature DB >> 17417686

Cell-specific regulation of APOBEC3F by interferons.

Songcheng Ying1, Xuzhao Zhang, Phuong Thi Nguyen Sarkis, Rongzhen Xu, Xiaofang Yu.   

Abstract

Human cytidine deaminase APOBEC3F (A3F) has broad anti-viral activity against hepatitis B virus and retroviruses including human immunodeficiency virus type 1. However, its regulation in viral natural target cells such CD4+ T lymphocytes, macrophages, and primary liver cells has not been well studied. Here we showed that A3F was up-regulated by interferon (IFN)-alpha in primary hepatocytes and multiple liver cell lines as well as macrophages. Although the IFN-alpha signaling pathway was active in T lymphoid cells and induction of other IFN stimulated genes such as PKR was detected, A3F and APOBEC3G (A3G) were not induced by IFN-alpha in these cells. Thus, additional factors other than known IFN-stimulated genes also regulated IFN-alpha-induced A3F expression distinctly. A3F and A3G expression levels in primary hepatocytes, especially after IFN-alpha stimulation, were comparable to those in CD4+ T lymphocytes in some individuals. Significant variations of A3F and A3G expression in primary hepatocytes from various subjects were observed. Individual variations in A3F and/or A3G regulation and expression might influence the clinical outcomes of hepatitis B infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17417686     DOI: 10.1111/j.1745-7270.2007.00275.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  15 in total

1.  NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Authors:  Melissa A Farrow; Eun-Young Kim; Steven M Wolinsky; Ann M Sheehy
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

2.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  IFN-α and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways.

Authors:  Harshini V Mehta; Philip H Jones; Jerrold P Weiss; Chioma M Okeoma
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

4.  Stably expressed APOBEC3F has negligible antiviral activity.

Authors:  Eri Miyagi; Charles R Brown; Sandrine Opi; Mohammad Khan; Ritu Goila-Gaur; Sandra Kao; Robert C Walker; Vanessa Hirsch; Klaus Strebel
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

5.  APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.

Authors:  Chawaree Chaipan; Jessica L Smith; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.

Authors:  Lindi Tan; Phuong Thi Nguyen Sarkis; Tao Wang; Chunjuan Tian; Xiao-Fang Yu
Journal:  FASEB J       Date:  2008-09-30       Impact factor: 5.191

7.  Correlation of APOBEC3 in tumor tissues with clinico-pathological features and survival from hepatocellular carcinoma after curative hepatectomy.

Authors:  Zongguo Yang; Yunfei Lu; Qingnian Xu; Liping Zhuang; Bozong Tang; Xiaorong Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.

Authors:  Fransje A Koning; Edmund N C Newman; Eun-Young Kim; Kevin J Kunstman; Steven M Wolinsky; Michael H Malim
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

9.  The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system.

Authors:  Elias G Argyris; Edward Acheampong; Fengxiang Wang; Jialing Huang; Keyang Chen; Muhammad Mukhtar; Hui Zhang
Journal:  Virology       Date:  2007-07-12       Impact factor: 3.616

10.  Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Jason T Kimata
Journal:  Biology (Basel)       Date:  2012-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.